Literature DB >> 26342640

The Risk of Cardiovascular Events After an Acute Coronary Event Remains High, Especially During the First Year, Despite Revascularization.

Emad Abu-Assi1, Andrea López-López2, Violeta González-Salvado2, Alfredo Redondo-Diéguez2, Carlos Peña-Gil2, Noelia Bouzas-Cruz2, Sergio Raposeiras-Roubín2, Rami Riziq-Yousef Abumuaileq2, José M García-Acuña2, José R González-Juanatey2.   

Abstract

INTRODUCTION AND
OBJECTIVES: There is little information on the incidence and predictors of infarction, stroke, or cardiovascular death after acute coronary syndrome. We investigated these aspects and developed tools for predicting these events according to the time of their occurrence.
METHODS: A retrospective study was conducted of 4858 patients who survived an acute coronary event. We analyzed the incidence and predictors of acute myocardial infarction, stroke, or cardiovascular death during the first year (n=4858) vs successive years (n=4345 patients free of composite events during the first year).
RESULTS: There were 329 events in the first year (cumulative incidence function: 7.3% person-years) and 616 in successive years (21.5% person-years; follow-up 4.9±2.4 years). The risk of events during the first year per tertile was 2.5% person-years in the low-risk tertile (< 3 points), 4.8% person-years in the intermediate-risk tertile (3-6 points), and 15.5% person-years in the high-risk tertile (> 6 points) (P<.001). The risk of events in the cohort that had a combined event in successive years increased from 10.7% person-years in the low-risk tertile (< 3 points) to 40.3% person-years in the high-risk tertile (> 6 points) (P<.001). The 2 scales showed the following predictive indexes: C statistic, 0.74 and 0.69, respectively; P (Hosmer-Lemeshow test)≥0.44
CONCLUSION: The risk of recurrence of cardiovascular events remains high after acute coronary syndrome. The level of risk can be easily quantified with acceptable predictive ability.
Copyright © 2015 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Acute myocardial infarction; Escala; Incidence; Incidencia; Infarto agudo de miocardio; Predictores; Predictors; Prognosis; Pronóstico; Scale

Mesh:

Year:  2015        PMID: 26342640     DOI: 10.1016/j.rec.2015.06.015

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  8 in total

1.  Prognostic Value of New-Generation Troponins in ST-Segment-Elevation Myocardial Infarction in the Modern Era: The RUTI-STEMI Study.

Authors:  Germán Cediel; Ferran Rueda; Cosme García; Teresa Oliveras; Carlos Labata; Jordi Serra; Julio Núñez; Vicent Bodí; Marc Ferrer; Josep Lupón; Antoni Bayes-Genis
Journal:  J Am Heart Assoc       Date:  2017-12-23       Impact factor: 5.501

2.  Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study.

Authors:  Cengiz Özcan; Anna Deleskog; Anne-Marie Schjerning Olsen; Helene Nordahl Christensen; Morten Lock Hansen; Gunnar Hilmar Gislason
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2018-01-01

3.  Lipid-lowering therapy and low-density lipoprotein cholesterol goal attainment after acute coronary syndrome: a Danish population-based cohort study.

Authors:  Marie Skov Kristensen; Anders Green; Mads Nybo; Simone Møller Hede; Kristian Handberg Mikkelsen; Gunnar Gislason; Mogens Lytken Larsen; Annette Kjær Ersbøll
Journal:  BMC Cardiovasc Disord       Date:  2020-07-13       Impact factor: 2.298

4.  Predictive performance of aortic arch calcification for clinical outcomes in patients with acute coronary syndrome that undergo percutaneous coronary intervention: A prospective clinical study.

Authors:  Xiaoteng Ma; Lisha Dong; Qiaoyu Shao; Zhen Zhou; Jing Tian; Yue Ma; Jie Yang; Sai Lv; Yujing Cheng; Hua Shen; Lixia Yang; Zhijian Wang; Yujie Zhou
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

5.  Baseline Serum sLOX-1 Concentrations Are Associated with 2-Year Major Adverse Cardiovascular and Cerebrovascular Events in Patients after Percutaneous Coronary Intervention.

Authors:  Zi-Wen Zhao; Yi-Wei Xu; Shu-Mei Li; Jin-Jian Guo; Jian-Min Sun; Ju-Chang Hong; Liang-Long Chen
Journal:  Dis Markers       Date:  2019-10-20       Impact factor: 3.434

6.  High Lipoprotein(a) Levels as a Predictor of Major Adverse Cardiovascular Events in Hospitalized-Acute Myocardial Infarction Patients.

Authors:  I Dewa Gde Dwi Sumarjaya; I Ketut Badjra Nadha; Anak Agung Wiradewi Lestari
Journal:  Vasc Health Risk Manag       Date:  2020-04-08

7.  Evaluation of the Use of Dual Antiplatelet Therapy beyond the First Year after Acute Coronary Syndrome.

Authors:  Clara Bonanad; Sergio Raposeiras-Roubin; Sergio García-Blas; Iván Núñez-Gil; Carlos Vergara-Uzcategui; Pablo Díez-Villanueva; Jordi Bañeras; Clara Badía Molins; Jaime Aboal; Jose Carreras; Vicente Bodi; Ana Gabaldón-Pérez; Gemma Mateus-Porta; Jose Antonio Parada Barcia; Manuel Martínez-Sellés; Francisco Javier Chorro; Albert Ariza-Solé
Journal:  J Clin Med       Date:  2022-03-17       Impact factor: 4.241

8.  Prognostic value of CHADS2 and CHA2DS2-VASc scores for post-discharge outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.

Authors:  Xiaoteng Ma; Qiaoyu Shao; Lisha Dong; Yujing Cheng; Sai Lv; Hua Shen; Jing Liang; Zhijian Wang; Yujie Zhou
Journal:  Medicine (Baltimore)       Date:  2020-07-24       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.